Sequella, Inc., a clinical stage biopharmaceutical company, develops products for the diagnosis and treatment of infectious diseases. The company focuses on commercializing treatment paradigms for diseases of epidemic potential. It develops TB Patch for the diagnosis of active TB; SQ109 for the treatment of TB; drug compliance monitor, a device for application in multiple drug therapies; SQ609...